Repealing the Affordable Care Act could hurt physicians and hospitals
While the overall effects are nuanced, primary care physicians and small practices will likely bear the brunt of a financial hit if the ACA is repealed.
Physicians
Is pharma too physician-centric? Why industry may want to rethink its approach to NPs and PAs
They’ve boosted access to care, and now NPs and PAs are seeing increased practice authority. The changes warrant an industry rethink, two clinician leaders argue.
AbelsonTaylor/Veeva report: Physicians are adjusting to COVID-era uncertainty, but want support from pharma
For “Managing Uncertainty: Helping Physicians Survive in the Short-Term and Thrive in the Long-Term,” the companies surveyed 550 doctors.
ZDoggMD is redefining the scope and tone of physician influence on social media
Dr. Zubin Damania is known across the social media universe as ZDoggMD.
Who’s your prescriber now? Demand for NPs and PAs is booming, according to report
Recent healthcare trends, including a physician shortage and the rise of value-based care centers, have put NPs and PAs on the fast track to recruiter popularity. Marketers, take note.
Health brands need to consider the human side of patients, HCPs, and stakeholders
Croom Lawrence and Kent Groves of Merkle Health explain being human.
Xbox for Docs: Pharma backs AR games for use in physician learning
Pharma has backed a number of AR-based games for physician learning and marketing. They’re meant to complement live learning, but mobile games may do a better job teaching certain skills.
Five things for pharma marketers to know: Wednesday, January 17, 2018
Celgene reportedly in talks to buy Juno; Novartis’ Kymriah receives fast-track reviews in U.S. and Europe; BI’s Gilotrif gets expanded approval in lung cancer
Five things for pharma marketers to know: Thursday, December 28, 2017
Study: male docs earn more than female peers; new Michigan law tackles opioid crisis; study: some docs billed Medicare for most expensive patient visit type
Five things for pharma marketers to know: Wednesday, December 20, 2017
Tax bill could lead pharma to move overseas; global pharma sales increased 45% in nine years; FDA OKs first gene therapy for rare retinal disease
